G. Stathopoulos

611 total citations
23 papers, 525 citations indexed

About

G. Stathopoulos is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, G. Stathopoulos has authored 23 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in G. Stathopoulos's work include Cancer Treatment and Pharmacology (7 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Lung Cancer Treatments and Mutations (5 papers). G. Stathopoulos is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Lung Cancer Treatments and Mutations (5 papers). G. Stathopoulos collaborates with scholars based in Greece, Brazil and Germany. G. Stathopoulos's co-authors include S. Rigatos, Gerasimos Aravantinos, George Fountzilas, Pavlos Papakotoulas, K. Syrigos, Nikolaos Ziras, Vassilis Georgoulias, Nikolaos Androulakis, George Samonis and Anna Potamianou and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

G. Stathopoulos

22 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Stathopoulos Greece 13 427 176 153 112 88 23 525
Emiddio Barletta Italy 12 395 0.9× 336 1.9× 82 0.5× 81 0.7× 92 1.0× 28 584
D. P. Ryan United States 13 241 0.6× 180 1.0× 83 0.5× 44 0.4× 94 1.1× 31 510
S. Rigatos Greece 13 396 0.9× 200 1.1× 99 0.6× 56 0.5× 66 0.8× 31 497
Federico Castiglione Italy 8 333 0.8× 142 0.8× 138 0.9× 50 0.4× 100 1.1× 12 465
Enzo Veltri Italy 10 353 0.8× 150 0.9× 61 0.4× 57 0.5× 71 0.8× 13 421
S Jelić Serbia 10 225 0.5× 84 0.5× 91 0.6× 84 0.8× 67 0.8× 38 443
E. Mickiewicz Argentina 9 372 0.9× 166 0.9× 197 1.3× 34 0.3× 72 0.8× 15 639
Kota Ouchi Japan 12 251 0.6× 110 0.6× 163 1.1× 29 0.3× 164 1.9× 42 503
Ulla Lau‐Werner Germany 10 341 0.8× 126 0.7× 69 0.5× 28 0.3× 86 1.0× 13 463
Michihiro Koizumi Japan 14 366 0.9× 106 0.6× 234 1.5× 42 0.4× 153 1.7× 52 604

Countries citing papers authored by G. Stathopoulos

Since Specialization
Citations

This map shows the geographic impact of G. Stathopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Stathopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Stathopoulos more than expected).

Fields of papers citing papers by G. Stathopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Stathopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Stathopoulos. The network helps show where G. Stathopoulos may publish in the future.

Co-authorship network of co-authors of G. Stathopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of G. Stathopoulos. A scholar is included among the top collaborators of G. Stathopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Stathopoulos. G. Stathopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stathopoulos, G.. (2011). Reply to Dr. Kabbinavar and Dr. Kozloff. Oncology. 80(1-2). 140–141. 1 indexed citations
2.
Stathopoulos, J., Athanasios Armakolas, G. Stathopoulos, & Ilias P. Gomatos. (2010). Plasma VEGF levels in breast cancer patients with and without metastases. Oncology Letters. 1(4). 739–741. 9 indexed citations
3.
Stathopoulos, G., et al.. (2007). Liposomal cisplatin and paclitaxel versus cisplatin and paclitaxel in advanced NSCLC. Journal of Clinical Oncology. 25(18_suppl). 7684–7684. 1 indexed citations
4.
Stathopoulos, G., K. Syrigos, Gerasimos Aravantinos, et al.. (2006). A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer. British Journal of Cancer. 95(5). 587–592. 167 indexed citations
5.
6.
Stathopoulos, G., D. Tsavdaridis, N. Malamos, et al.. (2005). Irinotecan combined with docetaxel in pre-treated metastatic breast cancer patients: a phase II study. Cancer Chemotherapy and Pharmacology. 56(5). 487–491. 18 indexed citations
7.
Stathopoulos, G., K. Syrigos, Aristidis Polyzos, et al.. (2004). Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study. Annals of Oncology. 15(2). 224–229. 48 indexed citations
8.
Stathopoulos, G., S. Rigatos, Meletios Α. Dimopoulos, et al.. (2003). Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer. Annals of Oncology. 14(3). 388–394. 39 indexed citations
9.
Bafaloukos, Dimitrios, Gerasimos Aravantinos, George Fountzilas, et al.. (2002). Docetaxel in Combination with Dacarbazine in Patients with Advanced Melanoma. Oncology. 63(4). 333–337. 16 indexed citations
10.
Stathopoulos, G., Dimitriοs Mavroudis, Νicolas Tsavaris, et al.. (2001). Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: A phase II study of the Greek Cooperative Group for Pancreatic Cancer. Annals of Oncology. 12(1). 101–103. 58 indexed citations
11.
Giatromanolaki, Alexandra, G. Stathopoulos, Michael I. Koukourakis, et al.. (2001). Angiogenesis and Apoptosis-Related Protein (p53, bcl-2, and bax) Expression Versus Response of Gastric Adenocarcinomas to Paclitaxel and Carboplatin Chemotherapy. American Journal of Clinical Oncology. 24(3). 222–226. 9 indexed citations
12.
Voutsas, Ioannis F., Constantin N. Baxevanis, Angelos D. Gritzapis, et al.. (2000). Synergy between interleukin-2 and prothymosin ? for the increased generation of cytotoxic T lymphocytes against autologous human carcinomas. Cancer Immunology Immunotherapy. 49(8). 449–458. 19 indexed citations
13.
Kouroussis, Ch., Stylianos Kakolyris, G. Stathopoulos, et al.. (2000). Phase I study of weekly Docetaxel (D) and Gemcitabine (G) in advanced non-small cell lung cancer. Lung Cancer. 29(1). 43–43. 4 indexed citations
14.
Stathopoulos, G., S. Rigatos, & N. Malamos. (1999). Paclitaxel combined with cis-platin as second-line treatment in patients with advanced non-small cell lung cancers refractory to cis-platin.. Oncology Reports. 6(4). 797–800. 22 indexed citations
15.
Stathopoulos, G., et al.. (1999). Inhibition of adriamycin cardiotoxicity by 5-fluorouracil: a potential free oxygen radical scavenger.. PubMed. 18(6A). 4387–92. 14 indexed citations
16.
Androulakis, N., G. Stathopoulos, E. Samantas, et al.. (1999). First line treatment with docetaxel (D) and gemcitabine (G) in patients with inoperable pancreatic cancer: a multicenter phase II study. European Journal of Cancer. 35. S142–S143. 4 indexed citations
17.
Stathopoulos, G., et al.. (1997). An increase of serum lipids after cumulative doses of doxorubicin and epirubicin in experimental animals.. PubMed. 16(6B). 3429–33. 10 indexed citations
18.
Fountzilas, George, E. Samantas, D. Skarlos, et al.. (1997). Paclitaxel and carboplatin in recurrent or metastatic head and neck cancer: a phase II study.. PubMed. 24(1 Suppl 2). S2–65. 12 indexed citations
19.
Stathopoulos, G., et al.. (1997). Long term breast cancer treatment with tamoxifen and second primary tumors. European Journal of Cancer. 33. S150–S151. 1 indexed citations
20.
Stathopoulos, G., C N Baxevanis, Nikolaos G. Papadopoulos, et al.. (1996). Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.. PubMed. 16(6B). 3855–60. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emiddio Barletta Breakdown of academic impact, for papers by D. P. Ryan Breakdown of academic impact, for papers by S. Rigatos Breakdown of academic impact, for papers by Federico Castiglione Breakdown of academic impact, for papers by Enzo Veltri Breakdown of academic impact, for papers by S Jelić Breakdown of academic impact, for papers by E. Mickiewicz Breakdown of academic impact, for papers by Kota Ouchi Breakdown of academic impact, for papers by Ulla Lau‐Werner Breakdown of academic impact, for papers by Michihiro Koizumi
Rankless by CCL
2026